Tyra Biosciences, Inc. (TYRA) NASDAQ

22.11

+0.41(+1.89%)

Updated at December 04 04:00PM

Currency In USD

Valuation

Market Cap795.33M
Enterprise Value709.58M
P/E Ratio-12.28
PEG Ratio1.33
Price/Sales Ratio2,347.94
Price/Book Ratio4.3
Enterprise/Revenue2,161.52
Enterprise/EBITDA-8.85

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-213.37
Operating Margin-245.26

Management Effectiveness

Return On Assets-0.33
Return On Equity-0.32

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit0
EBITDA-103.66M
Net Income-86.48M
Diluted EPS-1.51

Balance Sheet

Total Cash274.92M
Total Cash/Share4.98
Total Debt5.92M
Total Debt/Equity0.02
Current Ratio21.94
Book Value Per Share5.07

Price History

52-Week Change41.96
52-Week High22.83
52-Week Low6.42
Moving Average 50 Days15.76
Moving Average 200 Days11.82

Statistics

Average Volume299,874
Shares Outstanding53.37M
% Held by Institutions93.43

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A